đŽ $BIO â Crash or Liftoff?
$BIO has been on a wild ride. After spiking to $0.3254, it pulled back hard and is now trading around $0.20, still holding strong compared to where it was just weeks ago. The 1D chart shows that the sell-off has slowed, volume is steady, and buyers are starting to defend this zone.
The news around BIO is fueling the fire. Over 152 million tokens are staked, about 9% of supply, showing heavy commitment. The flip side is nearly half of those unlock within a week and over 60% in 30 days, which could trigger some sharp moves.
At the same time, BIOâs new launchpad project Aubrai is bringing real momentum. Itâs already oversubscribed more than five times ahead of its token launch on August 27, combining DeSci funding and AI-driven research. That hype pushed BIO to record highs last week and keeps attention locked in.
Right now BIO is sitting on the edge. If selling from unlocks outweighs demand, price could slide back toward $0.15â0.17. But if Aubrai delivers and the DeSci narrative keeps running, a bounce toward $0.30+ isnât out of the question.
From this view, BIO feels less like itâs ending and more like itâs setting up for the next big chapter.
